HVC
GMDA

Healthcare Value Capital’s Gamida Cell Ltd. Ordinary Shares GMDA Stock Holding History

Healthcare Value Capital’s Portfolio GMDA Stock Details GMDA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		$392K Buy
100,000
+25,000
+33% +$125K 0.77% 23
2021
Q2 		$481K Buy
75,000
+25,000
+50% +$172K 0.96% 23
2021
Q1 		$405K Hold
50,000
– – 0.9% 22
2020
Q4 		$420K Buy
+50,000
New +$338K 1.42% 17

Other funds holding GMDA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
LNWTC
Laird Norton Wetherby Trust Company Seattle, Washington $4.58B AUM 30.77% 1-Year Est. Return
AS
Altshuler Shaham Tel Aviv, Israel $5.54B AUM 44.68% 1-Year Est. Return

Healthcare Value Capital's GMDA Position: Q3 2021 in Review

Healthcare Value Capital increased its Gamida Cell Ltd. Ordinary Shares (GMDA) stake by 33% in Q3 2021, buying an estimated $125K and bringing the position to 100,000 shares worth $392K. The position accounts for 0.77% of the portfolio, ranked #23.

Healthcare Value Capital first reported a position in GMDA in Q4 2020 and has held it in 4 quarters since. The position peaked at $481K in Q2 2021. 73 funds tracked by Wall St. Rank hold GMDA as of Q3 2021.

  • Healthcare Value Capital held 100,000 shares of Gamida Cell Ltd. Ordinary Shares worth $392K as of Q3 2021.
  • Healthcare Value Capital bought 25,000 Gamida Cell Ltd. Ordinary Shares shares in Q3 2021, an estimated $125K.
  • Gamida Cell Ltd. Ordinary Shares made up 0.77% of Healthcare Value Capital's portfolio in Q3 2021, its #23 holding.
  • Healthcare Value Capital first reported a position in Gamida Cell Ltd. Ordinary Shares in Q4 2020 and has held it in 4 quarters since.
  • Healthcare Value Capital's Gamida Cell Ltd. Ordinary Shares position peaked at $481K in Q2 2021.
  • 73 funds tracked by Wall St. Rank held Gamida Cell Ltd. Ordinary Shares as of Q3 2021.

Based on Healthcare Value Capital's 13F filing for Q3 2021, filed 15 Nov 2021.